| Literature DB >> 30723745 |
Hak Yong Lee1, Young Mi Park1, Jeong Kim2, Hong Geun Oh3, Kang Sung Kim4, Hee Joo Kang5, Ri Rang Kim5, Min Jung Kim5, Sang Hee Kim5, Hye Jeong Yang5, Jisun Oh6.
Abstract
In this study, we evaluated the immunity-enhancing effects of Orostachys japonicus A. Berger (OJ). To examine the immune protective effect in vitro, primary mouse splenocytes were treated with water or ethanol extracts of OJ in the absence or presence of cyclophosphamide (CY), which is a cytotoxic, immunosuppressive agent. The extracts increased the propagation of splenocytes and inhibited CY-induced cytotoxicity. Further, to examine the immunostimulatory effects in vivo, adult Wistar rats were orally administered OJ extracts with or without CY treatment. With the administration of OJ extracts, CY-treated immunosuppressed rats showed improved physical endurance, as assessed by the forced swim test. In addition, extract administration increased not only the number of immunity-related cells but also the levels of plasma cytokines. OJ extracts also recovered splenic histology in CY-treated rats. These findings suggest that an OJ regimen can enhance immunity by increasing immune cell propagation and specific plasma cytokine levels.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30723745 PMCID: PMC6339714 DOI: 10.1155/2019/9461960
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1OJ extracts increased splenocyte proliferation and protected against CY-induced splenocyte damage. (a–b) The number of isolated splenocytes was augmented with OJWE (a) or OJEE (b) treatment. (c–d) CY-induced splenocyte cytotoxicity was abolished by OJWE (c) or OJEE (d) treatment. Values represent mean ± standard error of the mean (SEM) from three independent experimental sessions (N = 3). Bars not sharing common letter represent statistically significant difference from each other (p < 0.05).
Figure 2OJ extracts increased white blood cell counts in immunosuppressed rats. (a) Swimming duration in the forced swim test. (b–e) White blood cell (WBC) counts: (b) total number of WBCs, (c) lymphocyte counts, (d) granulocyte counts, and (e) monocyte counts. The data obtained from individual animal samples per group were averaged (n = 8); values represent mean ± standard deviation (SD). Bars not sharing common letter represent statistically significant difference from each other (p < 0.05).
Figure 3OJ extracts increased immunity-associated plasma cytokine levels. (a) Plasma TNF-α level. (b) Plasma IFN-γ level. (c) Plasma IL-2 level. Values represent mean ± SD (n = 8). Bars not sharing common letter represent statistically significant difference from each other (p < 0.05). (d) Representative images of sectioned spleens: (A) normal (no treatment), (B) only CY-treated, (C) OJWE-low, OJWE administered at 100 mg/kg with CY treatment; (D) OJWE-high, OJWE administered at 1,000 mg/kg with CY treatment; (E) OJEE-low, OJEE administered at 100 mg/kg with CY treatment; and (F) OJEE-high, OJEE administered at 1,000 mg/kg with CY treatment. Scale bar in A, 100 μm, applicable to B–F. CV, central vein; MZ, marginal zone; RP, red pulp; WP, white pulp.